Immunovant

$15.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.37 (-2.36%) As of 7:44 PM UTC today

Why Robinhood?

You can buy or sell Immunovant and other stocks, options, and ETFs commission-free!

About IMVT

Immunovant, Inc. Common Stock, also called Immunovant, is a clinical-stage biopharmaceutical company.

CEO

Peter Salzmann

Employees

—

Headquarters

New York, New York

Founded

2018

Market Cap

1.48B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

721.01K

High Today

$15.51

Low Today

$15.11

Open Price

$15.51

Volume

258.78K

52 Week High

$53.75

52 Week Low

$11.80

Analyst Ratings

90%

of 10 ratings

Buy

90%

Hold

10%

Sell

IMVT Earnings

-$0.38

-$0.25

-$0.13

$0.00

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected Jun 28, Pre-Market